Diagnosis and Management of Fetal Growth Restriction
DOI:
10.29303/jbt.v23i4.5447Published:
2023-09-01Downloads
Abstract
Fetal Growth Restriction (FGR) or Intrauterine Growth Restriction (IUGR) is one of the complications in pregnancy that is quite common, especially in developing countries, which is one of the contributors to neonatal mortality and morbidity rates. This literature review aims to provide related information, so that proper diagnosis and management can be carried out to reduce fetal morbidity and mortality rates. We searched from online databases and used review articles, research, guidelines from professional organizations, such as POGI from Indonesia, ACOG from the USA, and RCOG from the UK. Risk factor assessment and examination of fundal height can be the first steps in diagnosing IUGR. If suspicion is found, ultrasound (USG) and Doppler velocimetry can be performed. IUGR management mostly works in influencing the vasodilation of the placenta as the most common cause of IUGR events. Fetal Growth Restriction can be diagnosed immediately by screening for risk factors in pregnant women.
Keywords:
Diagnosis, intrauterine growth restriction, management, risk factor.References
ACOG. (2020). Fetal Growth Restriction: ACOG Practice Bulletin, Number 227: Vol. 137(2). DOI: https://doi.org/10.1097/AOG.0000000000004251
Armengaud, J. B., Yzydorczyk, C., Siddeek, B., Peyter, A. C., & Simeoni, U. (2021). Intrauterine growth restriction: Clinical consequences on health and disease at adulthood. Reproductive Toxicology, 99, 168–176. DOI: https://doi.org/10.1016/j.reprotox.2020.10.005
Banjac, L., Kotur-Stevuljević, J., Gojković, T., Bokan-Mirković, V., Banjac, G., & Banjac, G. (2020). Relationship Between Insulin-Like Growth Factor Type 1 and Intrauterine Growth. Acta Clinica Croatica, 59(1), 91–96. DOI: https://doi.org/10.20471/acc.2020.59.01.11
Beaumann, M., Delhaes, F., Menétrey, S., Joye, S., Vial, Y., Baud, D., Magaly, J. G., Tolsa, J. F., & Peyter, A. C. (2020). Intrauterine growth restriction is associated with sex-specific alterations in the nitric oxide/cyclic GMP relaxing pathway in the human umbilical vein. Placenta, 93, 83–93. DOI: https://doi.org/10.1016/j.placenta.2020.02.014
Chen, J., Gong, X., Chen, P., Luo, K., & Zhang, X. (2016). Effect of L-arginine and sildenafil citrate on intrauterine growth restriction fetuses: A meta-analysis. BMC Pregnancy and Childbirth, 16(1). DOI: https://doi.org/10.1186/s12884-016-1009-6
Damhuis, S. E., Ganzevoort, W., & Gordijn, S. J. (2021). Abnormal Fetal Growth: Small for Gestational Age, Fetal Growth Restriction, Large for Gestational Age: Definitions and Epidemiology. Obstet Gynecol Clin N Am, 48(2), 267–279. DOI: https://doi.org/https://doi.org/10.1016/j.ogc.2021.02.002
Irwantoro, G., Hidayat, D., & Aziz, M. A. (2021). Prevalensi dan Faktor Risiko pada Pasien Intrauterin Growth Restriction di Rumah Sakit Umum Pusat Dr. Hasan Sadikin Bandung. Indonesian Journal of Obstetrics & Gynecology Science, 4(2), 111–117.
Kaur, H., Muhlhausler, B. S., Roberts, C. T., & Gatford, K. L. (2021). The growth hormone-insulin-like growth factor axis in pregnancy. Journal of Endocrinology, 251(3), R23–R39. DOI: https://doi.org/10.1530/JOE-21-0087
Khalaf, D., Krüger, M., Wehland, M., Infanger, M., & Grimm, D. (2019). The effects of oral l-arginine and l-citrulline supplementation on blood pressure. Nutrients, 11(7). DOI: https://doi.org/10.3390/nu11071679
Maged, M., Wageh, A., Shams, M., & Elmetwally, A. (2018). Use of sildenafil citrate in cases of intrauterine growth restriction (IUGR); a prospective trial. Taiwanese Journal of Obstetrics and Gynecology, 57(4), 483–486. DOI: https://doi.org/10.1016/j.tjog.2018.06.00
Martín-Estal, I., De La Garza, R. G., & Castilla-Cortázar, I. (2016). Intrauterine growth retardation (IUGR) as a novel condition of insulin-like growth factor-1 (IGF-1) deficiency. Reviews of Physiology, Biochemistry and Pharmacology, 170(3000). DOI: https://doi.org/10.1007/112_2015_5001
Martins, J. G., & abuhamad, A. (2022). Fetal Growth Restriction. In Maternal-Fetal Evidence based Guidelines (Vol. 4, pp. 482–499). DOI: https://doi.org/10.1201/9781003099062-47
Nardozza, L. M. M., Caetano, A. C. R., Zamarian, A. C. P., Mazzola, J. B., Silva, C. P., Marçal, V. M. G., Lobo, T. F., Peixoto, A. B., & Araujo Júnior, E. (2017). Fetal growth restriction: current knowledge. Archives of Gynecology and Obstetrics, 295(5), 1061–1077. DOI: https://doi.org/10.1007/s00404-017-4341-9
Nardozza, L. M. M., Caetano, A. C. R., Zamarian, A. C. P., Mazzola, J. B., Silva, C. P., Marçal, V. M. G., Lobo, T. F., Peixoto, A. B., & Júnior, E. A. (2017). Fetal growth restriction: current knowledge. Arch Gynecol Obstet, 295, 1061–1077. DOI: https://doi.org/10.1007/s00404-017-4341-9
Nawathe, A. R., Christian, M., Kim, S. H., Johnson, M., Savvidou, M. D., & Terzidou, V. (2016). Insulin-like growth factor axis in pregnancies affected by fetal growth disorders. Clinical Epigenetics, 8(1), 1–13. DOI: https://doi.org/10.1186/s13148-016-0178-5
Perkumpulan Obstetri dan Ginekologi Indonesia. (2016). Pedoman Nasional Pelayanan Kedokteran Pengelolaan Kehamilan Dengan Pertumbuhan Janin Terhambat.
RCOG. (2013). The Investigation and Management of The Small–for–Gestational–Age Fetus (2nd ed., Vol. 31).
Renes, J. S., Van Doorn, J., & Hokken-Koelega, A. C. S. (2019). Current Insights into the Role of the Growth Hormone-Insulin-Like Growth Factor System in Short Children Born Small for Gestational Age. Hormone Research in Paediatrics, 92(1), 15–27. https://doi.org/10.1159/000502739
Sharma, D., Shastri, S., & Sharma, P. (2016). Intrauterine Growth Restriction: Antenatal and Postnatal Aspects. Clinical Medicine Insights. Pediatrics, 10, 67–83. DOI: https://doi.org/10.4137/CMPed.S40070
Shehata, N. A. A., Ali, H. A. A., Fahim, A. S., Katta, M. A., & Hussein, G. K. (2020). Addition of sildenafil citrate for treatment of severe intrauterine growth restriction: a double blind randomized placebo controlled trial. Journal of Maternal-Fetal and Neonatal Medicine, 33(10), 1631–1637. DOI: https://doi.org/10.1080/14767058.2018.1523892
Spiroski, A. M., Oliver, M. H., Jaquiery, A. L., Gunn, T. D., Harding, J. E., & Bloomfield, F. H. (2020). Effects of intrauterine insulin-like growth factor-1 therapy for fetal growth restriction on adult metabolism and body composition are sex specific. American Journal of Physiology - Endocrinology and Metabolism, 318(4), E568–E578. DOI: https://doi.org/10.1152/ajpendo.00481.2019
Spiroski, A.-M., H. Oliver, M., E. Harding, J., & H. Bloomfield, F. (2016). Intrauterine Intervention for the Treatment of Fetal Growth Restriction. Current Pediatric Reviews, 12(3), 168–178. DOI: https://doi.org/10.2174/1573396312666160808151856
Spiroski, A.-M., Oliver, M. H., Harding, J. E., & Bloomfield, F. H. (2016). Intrauterine Intervention for the Treatment of Fetal Growth Restriction. Current Pediatric Reviews, 12(3), 168–178. DOI: https://doi.org/10.2174/1573396312666160808
Suhag, A., & Berghella, V. (2013). Intrauterine Growth Restriction (IUGR): Etiology and Diagnosis. Curr Obstet Gynecol Rep, 2, 102–111. DOI: https://doi.org/10.1007/s13669-013-0041-z
Tesfa, D., Tadege, M., Digssie, A., & Abebaw, S. (2020). Intrauterine growth restriction and its associated factors in South Gondar zone hospitals, Northwest Ethiopia, 2019. Tesfa et al. Archives of Public Health, 78(89), 1–9. DOI: https://doi.org/https://doi.org/10.1186/s13690-020-00475-2
Tiralongo, G. M., Pisani, I., Vasapollo, B., Khalil, A., Thilaganathan, B., & Valensise, H. (2018). Effect of a nitric oxide donor on maternal hemodynamics in fetal growth restriction. Ultrasound in Obstetrics and Gynecology, 51(4), 514–518. DOI: https://doi.org/10.1002/uog.17454
Weckman, A. M., McDonald, C. R., Baxter, J. A. B., Fawzi, W. W., Conroy, A. L., & Kain, K. C. (2019). Perspective: L-arginine and L-citrulline Supplementation in Pregnancy: A Potential Strategy to Improve Birth Outcomes in Low-Resource Settings. Advances in Nutrition, 10(5), 765–777. DOI: https://doi.org/10.1093/advances/nmz015
License
Copyright (c) 2023 Theophany Margareta Kurniawan, Pratiwi Anggraini, Meilisva Audila Anggraini
This work is licensed under a Creative Commons Attribution 4.0 International License.
Jurnal Biologi Tropis is licensed under a Creative Commons Attribution 4.0 International License.
The copyright of the received article shall be assigned to the author as the owner of the paper. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.
Authors are permitted to disseminate published articles by sharing the link/DOI of the article at the journal. Authors are allowed to use their articles for any legal purposes deemed necessary without written permission from the journal with an acknowledgment of initial publication to this journal.
